Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer-Reference-Cited by-同舟云学术

Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer

Published:2018-07-03 Issue:20 Volume:24 Page:4949-4959
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Karam Sana D.,Reddy Krishna,Blatchford Patrick J.,Waxweiler Tim,DeLouize Alicia M.,Oweida Ayman,Somerset Hilary,Marshall Carrie,Young Christian,Davies Kurtis D.,Kane Madeleine,Tan Aik Choo,Wang Xiao Jing,Jimeno Antonio,Aisner Dara L.,Bowles Daniel W.,Raben David

Funder

University of Colorado Cancer Center

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strahlentherapie und molekular zielgerichtete Therapie – alles gezielt?;Die Onkologie;2024-05-09

2. Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer;International Journal of Molecular Sciences;2024-04-03

3. Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial;International Journal of Radiation Oncology*Biology*Physics;2024-04

4. Development and Validation of a Pathomics Model Using Machine Learning to Predict <i>CXCL8</i> Expression and Prognosis in Head and Neck Cancer;Clinical and Experimental Otorhinolaryngology;2024-02-29

5. A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ALARM” study;Cancer Medicine;2024-01-21